Article thumbnail

Successful Memory Response following a Booster Dose with a Virosome-Formulated Hepatitis A Vaccine Delayed Up to 11 Years ▿

By Christoph Hatz, Robert van der Ploeg, Bernhard R. Beck, Gert Frösner, Marjory Hunt and Christian Herzog

Abstract

Boosting adult travelers with the virosome-formulated, aluminum-free hepatitis A vaccine Epaxal up to 128 months after a single primary dose confers full protection against hepatitis A, even in travelers aged 50 years and above. Delaying the booster dose did not influence the immune memory response to Epaxal

Topics: Vaccine Research
Publisher: American Society for Microbiology
OAI identifier: oai:pubmedcentral.nih.gov:3122528
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles